Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions
Feasibility of Transanal Robot-Assisted Resection of Distal Colorectal Lesions Using the Medrobotics Flex® System: A Pilot Study
2 other identifiers
interventional
2
1 country
1
Brief Summary
This clinical trial assesses the safety and effectiveness of a new device called the Flex Robotic System in the surgical removal (resection) of colorectal lesions. When an area of abnormal tissue called a lesion is found in the colon or rectum, it is often not known if the lesion is cancerous or non-cancerous. Recommendation to remove the lesion may be made. Current methods of resection can be challenging and time-consuming. The Flex Robotic System is a new device that provides a stable working environment, better ability to grasp and cut lesions, and better tissue handling when performing a resection. The Flex Robotic system may be more effective at removing colorectal lesions than standard resection techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2022
CompletedFirst Submitted
Initial submission to the registry
December 12, 2022
CompletedFirst Posted
Study publicly available on registry
January 6, 2023
CompletedJanuary 12, 2023
December 1, 2022
2.4 years
December 12, 2022
January 11, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Rates of complete en bloc resection
Rates of complete en bloc resection
Up to 2 years
Incidence of adverse events
The primary endpoint will be the Incidence of adverse events using the Flex Robotic System for distal colorectal lesions.
Up to 2 years
Study Arms (1)
Device Feasibility (Flex Robotic System)
EXPERIMENTALPatients undergo resection with Flex Robotic System on study. Patients also undergo colonoscopy with or without rectal endoscopic ultrasound at screening.
Interventions
Undergo rectal endoscopic ultrasound
Ancillary studies
Undergo resection with the Flex Robotic System
Undergo resection with the Flex Robotic System
Eligibility Criteria
You may qualify if:
- Age \>= 22 years (minimum age approved for use)
- Polypoid (0-Is) and non-polypoid (0-IIa, 0-IIb and 0-IIc) lateral spreading lesions according to Paris classification
- Colorectal lesions situated between 5 and 15 cm from the dentate line
- Colorectal mucosal lesions ranging from 1.5 to 7 cm in maximum diameter
- Colorectal subepithelial lesions \< 2 cm in size
- Absence of uncorrectable bleeding disorder or coagulopathy
- Platelet count \> 50,000
- International normalized ratio (INR) \< 1.5
- Ability to give informed consent
You may not qualify if:
- Inability to receive general anesthesia
- Presence of medical conditions for which a transanal approach is contraindicated (e.g., anal stricture, radiation proctopathy)
- Excavated (0-III) colorectal lesions according to Paris classification
- Suboptimal colon preparation
- Clinical discretion of the provider
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louis M Wong Kee Song
Mayo Clinic in Rochester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2022
First Posted
January 6, 2023
Study Start
January 15, 2020
Primary Completion
June 10, 2022
Study Completion
June 10, 2022
Last Updated
January 12, 2023
Record last verified: 2022-12